- -

Between Scylla and Charibdis: eIF2 alpha kinases as targets for cancer chemotherapy

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Between Scylla and Charibdis: eIF2 alpha kinases as targets for cancer chemotherapy

Show full item record

Moreno Torres, M.; Murguía, JR. (2011). Between Scylla and Charibdis: eIF2 alpha kinases as targets for cancer chemotherapy. Clinical & Translational Oncology. 13(7):442-445. doi:10.1007/s12094-011-0680-3

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/65736

Files in this item

Item Metadata

Title: Between Scylla and Charibdis: eIF2 alpha kinases as targets for cancer chemotherapy
Author:
UPV Unit: Universitat Politècnica de València. Instituto Universitario Mixto de Biología Molecular y Celular de Plantas - Institut Universitari Mixt de Biologia Molecular i Cel·lular de Plantes
Universitat Politècnica de València. Departamento de Biotecnología - Departament de Biotecnologia
Issued date:
Abstract:
[EN] The eIF2 alpha kinases integrate translation initiation rates with nutrient availability, thus allowing cells to adapt to nutrient scarcity. Recent evidence has uncovered new functions of these kinases in tumour cell ...[+]
Subjects: eIF2 alpha phosphorylation , GCN2 , PERK , PKR , Translation
Copyrigths: Cerrado
Source:
Clinical & Translational Oncology. (issn: 1699-048X )
DOI: 10.1007/s12094-011-0680-3
Publisher:
Springer
Publisher version: https://dx.doi.org/10.1007/s12094-011-0680-3
Type: Artículo

This item appears in the following Collection(s)

Show full item record